The group company held the 2018 annual board of directors and the board of supervisors to review and approve the annual work report and other related proposals
Release time:
2020-07-22
Group Company Convenes 2018 Board of Directors and Board of Supervisors
to Review and Approve Annual Work Report and Other Related Proposals
News 4 26 , Chairman of the Group Company Jiang Xiaomeng presided over the 10 Meeting of the 10th Board of Directors of the Company, deliberated and approved 22 related reports and proposals such as 2018 annual board of directors report and 2018 annual general manager business report.
General Manager's report pointed out that 2018 is the 31st anniversary of Peak Start-up 60#. According to the five-year development plan and annual business plan, the company has carried out various operation and management work in an orderly manner around the general policy of "determination to reform, deepen management, and promote all-round high-quality development of the enterprise " , the business plan formulated by the board of directors at the beginning of the year was well completed. The company realized operating income of 33.62 .7 billion yuan for the whole year, up 18.95% year on year, net profit attributable to shareholders 58,850.21 yuan, earnings per share reached 1.71 yuan, up 68.87% year on year, reaching a new record high. At the end of the year, total assets 49.01 .7 billion yuan, up 17.38% year on year; net assets attributable to shareholders were 31.63 .1 billion yuan, up 20.38% year on year.
With the deepening of the country's supply-side structural reform, the effect of cement de-capacity has been highlighted, 2018 The supply and demand relationship in most parts of the country has been better improved, and the overall profitability of the industry has been greatly improved. The company's cement subsidiaries adhere to the "cost leadership " strategy, through continuous optimization of organizational structure, strengthen technological transformation, effectively control production costs, improve labor productivity. Daye Jianfeng has continuously strengthened the construction of quality management system, strengthened the advanced nature of process technology, and completed a number of technical improvement projects, such as kiln tail preheater technical transformation, raw material mill technical transformation, kiln tail desulfurization technical transformation, and achieved good results. After scientific arrangement and implementation of the plan, sales volume and price have been improved. Yunnan Jianfeng firmly grasped the key projects and Jinghong market, and won the optimization of key projects with high-quality service and good reputation. While the sales volume increased, it ensured that the price continued to run at a high level. At the end of 2018 , the company made a decision to acquire all the shares of Guizhou huangpinggu longmingchuan cement co., ltd. and will continue to promote the construction of its off-site technological transformation project (with waste heat power generation) of its new dry cement production line with a daily output of 4500 tons of clinker, further expanding the company's main business scale and enhancing its core competitiveness. In
2018 , the growth rate of the pharmaceutical industry slowed down due to policies such as medical insurance fee control, bidding and price reduction, and 4+7 urban drug procurement. However, with the improvement of the aging degree of society and the enhancement of people's awareness of health care, the pharmaceutical market demand is strong. 2018 , Jianfeng Pharmaceutical carried out extensive investigation and project negotiation around the company's strategic planning, and achieved certain results. Jianfeng Pharmaceutical completed the holding and capital increase of Shanghai North Card, and acquired Anhui Zhongwang through Shanghai North Card, laying the foundation for Jianfeng Pharmaceutical to build a bulk drug manufacturing base and further improving the company's pharmaceutical business industry chain; the annual output of 20 .8 billion solid preparation project (international project) in Jinxi production base of Jianfeng pharmaceutical industry has been officially launched, and the planning and design, equipment selection, product screening and other work are progressing in an orderly manner. The establishment of Anhui Jianfeng Beika Pharmaceutical Small Molecule Targeted Drug Research Institute will further improve the company's research level of antineoplastic drugs. During the reporting period, the company increased its investment in drug research and development, and the clinical trials of Jianfeng Pharmaceutical's new anti-tumor drug DPT progressed steadily. The preclinical research of Jianfeng Yien antitumor drug JFAN-1001 is progressing smoothly. At present, preclinical toxicological, pharmacodynamic and pharmacokinetic studies have been fully carried out, and patent applications in the United States, Canada, Japan, Europe, Australia and China have been successfully completed. Jianfeng Pharmaceutical also has a number of new drugs in various stages of research and development. It has completed the pharmaceutical research of imatinib mesylate tablets and obtained BE filing. Completed the pharmaceutical research of desvenlafaxine succinate sustained-release tablets and passed the ethical review. New progress has been made in the work of "consistency evaluation " . The process, quality research and bioequivalence test of paroxetine hydrochloride tablets have been completed and reported to the National Drug Examination Center. In addition, in the face of "two-vote system " , "4+7 city drug volume procurement " and other policies brought about by market changes, the company actively formulate differentiated sales policies, integrate regional resources, and make useful attempts for marketing transformation.
2018 , the company's other business sectors also better achieved their business objectives, peak health continued to promote the common development of terminals and e-commerce, through the network platform, exhibitions, media and other ways to carry out investment, according to market changes to improve the marketing model. Jianfeng International Trade has completed the construction of the new warehouse (e-commerce logistics park) project, and introduced Aneng Logistics and Zhongtong Express into the park for operation. Peak Cable actively develop new customers, expand the OEM business, operating income has achieved a greater growth. On the day of
, the company also held the 107 meeting of 6 of the 9th board of supervisors, deliberated and approved the company's 2018 annual board of supervisors work report, 2018 annual financial final accounts report and other 9 related reports and proposals. (Yu Fruit)
More information
In the eastern corner of the production area of Jianfeng Health Technology Company, there is a very inconspicuous building. From below, only a few pipes of uneven thickness can be seen on the top and the slogan "Focus on Environmental Protection and Promote Sustainable Development" with red letters on the yellow background on the stainless steel guardrail. Walking up, you can only see several closed pools and a small room with stacks of documents, test tubes, glass bottles and other testing tools on the table. This is the peak and healthy sewage treatment station. The production sewage of the whole factory area is concentrated here. After adjustment (PH adjustment), pre-acidification, anaerobic, anoxic, aerobic (aeration), precipitation and other links, it is discharged into the pipe network after reaching the special discharge standard. Yin Zhiwu, executive deputy general manager of Jianfeng Health, said that because the sewage treatment station in Wucheng District has not yet been built, Jianfeng Health has not yet been able to achieve pipe discharge, and the relevant national laws have strict requirements on the discharge of water pollutants from the extraction pharmaceutical industry. Sewage discharge must reach a special discharge limit, that is, chemical oxygen demand (COD) must be less than 50 mg/L. Enterprise development and environmental protection are both the concept of peak health since its establishment. In March this year, on the basis of the original environmental protection facilities, Jianfeng Health carried out technical renovation of waste gas collection and treatment facilities, and at the same time installed a sealing cover on the sewage treatment station to realize the closed collection of waste gas. Since the trial operation of this facility in mid-May, the overall effect has been obvious. The original treatment tank would emit an unpleasant smell during work, but now the smell has been significantly reduced. Compared with the young enterprise of peak health, the relatively "older" peak pharmaceutical has more experience in sewage treatment and environmental protection. Akihama
2020
07-31
2016 Annual General Meeting of Shareholders
News from our newspaper On May 19, the on-site meeting of Jianfeng Group's 2016 Annual General Meeting of Shareholders was held in Conference Room 314 of Jianfeng Building to deliberate and pass the "2016 Annual Report on the Work of the Board of Directors" and other proposals. The meeting was convened by the board of directors of Jianfeng Group and chaired by Chairman Jiang Xiaomeng. A total of 6 shareholders and proxies attended the meeting, and the total number of voting shares held by them was 55,604,815, accounting for 16.16 of the total voting shares of the company. Some directors, supervisors and secretary of the board of directors of the company attended the meeting, and some senior managers attended the meeting as nonvoting delegates. The meeting was held and voted on by a combination of on-site voting and online voting, it deliberated and passed nine proposals, including the 2016 Work Report of the Board of Directors, the 2016 Work Report of the Board of Supervisors, the 2016 Financial Final Accounts Report, the 2016 Profit Distribution Proposal, the Proposal to Hire the Company's 2017 Audit Institution, the Proposal to Provide Guarantee to Holding Subsidiaries, the 2016 Annual Report and its Summary, the Election of Mr. Huang Sujian as Director of the Company and the Election of Mr. Chen Tianci as Supervisor of the Company. (Zhou Hengbin)
2020
07-31
2016 Annual General Meeting of Shareholders
News from our newspaper On May 19, the on-site meeting of Jianfeng Group's 2016 Annual General Meeting of Shareholders was held in Conference Room 314 of Jianfeng Building to deliberate and pass the "2016 Annual Report on the Work of the Board of Directors" and other proposals. The meeting was convened by the board of directors of Jianfeng Group and chaired by Chairman Jiang Xiaomeng. A total of 6 shareholders and proxies attended the meeting, and the total number of voting shares held by them was 55,604,815, accounting for 16.16 of the total voting shares of the company. Some directors, supervisors and secretary of the board of directors of the company attended the meeting, and some senior managers attended the meeting as nonvoting delegates. The meeting was held and voted on by a combination of on-site voting and online voting, it deliberated and passed nine proposals, including the 2016 Work Report of the Board of Directors, the 2016 Work Report of the Board of Supervisors, the 2016 Financial Final Accounts Report, the 2016 Profit Distribution Proposal, the Proposal to Hire the Company's 2017 Audit Institution, the Proposal to Provide Guarantee to Holding Subsidiaries, the 2016 Annual Report and its Summary, the Election of Mr. Huang Sujian as Director of the Company and the Election of Mr. Chen Tianci as Supervisor of the Company. (Zhou Hengbin)
2020
07-31
2016 Annual General Meeting of Shareholders
News from our newspaper On May 19, the on-site meeting of Jianfeng Group's 2016 Annual General Meeting of Shareholders was held in Conference Room 314 of Jianfeng Building to deliberate and pass the "2016 Annual Report on the Work of the Board of Directors" and other proposals. The meeting was convened by the board of directors of Jianfeng Group and chaired by Chairman Jiang Xiaomeng. A total of 6 shareholders and proxies attended the meeting, and the total number of voting shares held by them was 55,604,815, accounting for 16.16 of the total voting shares of the company. Some directors, supervisors and secretary of the board of directors of the company attended the meeting, and some senior managers attended the meeting as nonvoting delegates. The meeting was held and voted on by a combination of on-site voting and online voting, it deliberated and passed nine proposals, including the 2016 Work Report of the Board of Directors, the 2016 Work Report of the Board of Supervisors, the 2016 Financial Final Accounts Report, the 2016 Profit Distribution Proposal, the Proposal to Hire the Company's 2017 Audit Institution, the Proposal to Provide Guarantee to Holding Subsidiaries, the 2016 Annual Report and its Summary, the Election of Mr. Huang Sujian as Director of the Company and the Election of Mr. Chen Tianci as Supervisor of the Company. (Zhou Hengbin)
2020
07-30
Jianfeng Pharmaceutical Won Advanced Collective of Municipal Red Cross Humanitarian Promotion Award
On April 24, the Red Cross Society of Jinhua issued a circular commending the advanced units and individuals of the 2016 Red Cross Humanitarian Promotion Award. Peak Pharmaceutical Company won the Red Cross Humanitarian Promotion Award for Advanced Collective. The Red Cross is a social relief organization engaged in humanitarian work, with the purpose of carrying forward the spirit of humanity, fraternity and dedication, protecting human life and health, and promoting the cause of peace and progress of mankind. As a socially responsible enterprise, Jianfeng Pharmaceutical has always attached importance to public welfare and charity work, vigorously promoted the spirit of the Red Cross, and vigorously supported the work of the Red Cross with practical actions. In September 2016, at the theme publicity activity of "World First Aid Day" and the opening ceremony of the municipal Red Cross emergency rescue station (point), Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company, donated 6 AEDs known as "life-saving artifact" to the Red Cross on behalf of Jianfeng Pharmaceutical, it is equipped with six Red Cross emergency rescue service stations (points), namely, Jinhua high-speed railway station, sports center, cultural center, Shuanglong scenic spot, Siping village scenic spot and Suoyuan village scenic spot. The configuration of AED equipment has played a very good role in improving the emergency rescue capacity of Jinhua's key locations, and has been affirmed by the Red Cross and related units. (Spike Pharmaceuticals)
2020
07-31
Jingmai Airport Test Flight Successfully Runway Cement Spike Manufacturing
On April 7, a Boeing 737-700 aircraft of China Eastern Airlines Yunnan took off from Kunming. After completing two flight test subjects, it landed safely at Lancang Jingmai Airport. This not only marked the basic completion of the airport flight area, The official start of the test flight also marked that the "Peak" brand airport runway cement passed the first "final exam". Lancang Jingmai Airport is a major project with milestone significance in the history of Pu'er transportation construction. Since then, an air corridor connecting southwest Yunnan and Southeast Asia has been added between Kunming and Pu'er, which will greatly promote the development and utilization of tourism resources in Lancang, Menglian and Ximeng "Pu'er Green Triangle" area, and promote the sustainable development of local economy and society; it is of great significance to strengthen the city's national defense construction, maintain border stability, promote national unity, improve emergency rescue capabilities, and promote Pu'er's integration into the country's "Belt and Road" construction. Since the start of the construction of the airport, Yunnan Jianfeng has been paying close attention to it, organizing technical research and repeated tests, and finally produced high-quality airport runway special cement, and with excellent product quality, superior product performance and high-quality service, it has become a runway for Lancang Airport. Cement manufacturer. This not only fills the gap of "peak" airport special cement, but also is of great significance to promote the "peak" brand and improve the market influence of enterprises. It is understood that Jingmai Airport is initially confirmed to be officially opened to traffic at the end of May. (Li Liangping)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page